November study found Kalydeco improved lung function, reduced complications in patients with cystic fibrosis who have G551D mutation
Go here to see the original:
Cystic fibrosis drug Kalydeco approved by FDA: What does it mean for patients?
If you enjoyed this post, make sure you subscribe to my RSS feed!